Chittaranjan Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.19 M
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 127.50%
- Profit Growth 222.57%
- Ebitda 210.73%
- Net Worth 287.74%
- Total Assets 129.12%
About Chittaranjan Pharma
Chittaranjan Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 March 2014 and has a history of Ten years and ten months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.19 M, as per Ministry of Corporate Affairs (MCA) records.
Kushanava Pabi, Surya Mondal, Somnath Roy, and One other member serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900WB2014PTC200671
-
Company No.
200671
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Mar 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Chittaranjan Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kushanava Pabi
|
Director | 05-Mar-2014 | Current |
|
Surya Mondal
|
Director | 01-Jun-2017 | Current |
|
Somnath Roy
|
Director | 01-Jun-2017 | Current |
|
Nandan Gupta
|
Director | 05-Mar-2014 | Current |
Financial Performance of Chittaranjan Pharma.
Chittaranjan Pharma Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 127.5% increase. The company also saw a substantial improvement in profitability, with a 222.57% increase in profit. The company's net worth Soared by an impressive increase of 287.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chittaranjan Pharma?
In 2017, Chittaranjan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Burdwan Diagnostic & Research Centre Pvt LtdKushanava Pabi and Nandan Gupta are mutual person
-
Chittaranjan Clinic Private Limited
Kushanava Pabi is a mutual person
-
Narendra Dutta Education Private Limited
Surya Mondal, Somnath Roy and 1 more are mutual person
-
Medview Services Private Limited
Surya Mondal and Nandan Gupta are mutual person
-
Tansy Developers Private Limited
Surya Mondal is a mutual person
-
Narendra Gurukul Innovix Private Limited
Somnath Roy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chittaranjan Pharma?
Unlock and access historical data on people associated with Chittaranjan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chittaranjan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chittaranjan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.